Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-07-0610
European Journal of Endocrinology, Vol 158, Issue 3, 401-409
Copyright © 2008 by Society of the European Journal of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Sneve, M.
Right arrow Articles by Jorde, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sneve, M.
Right arrow Articles by Jorde, R.

CLINICAL STUDIES

The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: the Tromsø Study

Monica Sneve1, Nina Emaus2, Ragnar Martin Joakimsen3,4 and Rolf Jorde1,4

1 Department of Internal Medicine, University Hospital of North Norway, 9038 Tromsø, Norway2 Institute of Community Medicine, University of Tromsø, 9037 Tromsø, Norway3 Department of Nephrology, University Hospital of North Norway, 9038 Tromsø, Norway and 4 Institute of Clinical Medicine, University of Tromsø, 9037 Tromsø, Norway

(Correspondence should be addressed to M Sneve who is now at Medical Department B, Post box 101, University Hospital of North Norway, 9038 Tromsø, Norway; Email: monica.sneve{at}unn.no)

Objective: To explore the relation between serum parathyroid hormone (PTH) and bone mineral density (BMD), adjusted for lifestyle factors including smoking.

Design: Cross-sectional study.

Methods: The Tromsø Study is a population-based study performed for the fifth time in 2001. Serum PTH was measured and the subjects filled in a questionnaire covering lifestyle factors. BMD at the hip, distal and ultradistal forearm was measured.

Results: Complete datasets were available in 1442 men and 1368 women. Age, body mass index and serum PTH were strong predictors of BMD level at the hip in both genders. No significant relation was seen between serum PTH and BMD at the distal or ultradistal forearm. When smokers and non-smokers were analysed separately, the relation between PTH and BMD at the hip was significant in current non-smokers only. In males, current non-smokers had significantly higher BMD at all three measurement sites compared with current smokers. Male former smokers had values in between current and never smokers. There was a significant and negative relation between number of years smoked and BMD at the hip. In male former smokers, there was an increase in BMD with increasing years since smoking cessation.

Conclusion: Serum PTH is negatively associated with BMD at the hip, and the relation seems to be masked, or diminished, by smoking. Smoking reduces BMD at the hip, distal and ultradistal forearm in males, and the effect appears to be mainly time and not dose dependent.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of the European Journal of Endocrinology.